Kelong Pharmaceutical: As of the end of July, it has spent 10.366 million yuan to repurchase 350,000 shares.

Kelong Pharmaceutical announced that the company plans to repurchase shares for no more than 100 million yuan, with a repurchase price not exceeding 34.53 yuan per share. As of July 31, 2026, the company has repurchased 350,000 shares through centralized bidding, accounting for 0.02% of the total share capital, with a highest transaction price of 29.702 yuan per share and a lowest transaction price of 29.55 yuan per share, totaling a transaction amount of 10.366 million yuan. Future repurchases will be implemented based on market conditions and disclosed in a timely manner.